AlzeCure Pharma to present at Redeye Life Science Day on December 3

AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company is participating at Redeye Life Science Day 2024 on December 3 at 13:00 CET, where CEO Martin Jönsson and CSO Johan Sandin will participate in a Q&A and answer questions about the latest developments and the company's plans going forward.

Watch the livestream via https://www.redeye.se/events/1038747/redeye-technology-life-science-day.

The session will also be available afterwards on AlzeCure's company page at Redeye www.redeye.se/company/alzecure-pharma, and on AlzeCure's website www.alzecurepharma.se/en/presentations-and-interviews/.

Time: 08:30 - 18:00 CET, December 3, 2024
Venue: Sergelkonferensen, Mäster Samuelsgatan 42 (Sveavägen 9), Stockholm, Sweden

Datum 2024-11-26, kl 10:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.